Description
- Exclusive EPs 7630 extract clinically tested in over 20 clinical studies, including 9 prospective, randomized, double-blind, parallel-group, placebo-controlled clinical trials.
- Shortens the duration and reduces the severity of upper respiratory tract irritations.
- Studied in over 9,000 patients + addresses the underlying cause of symptoms to aid recovery and duration of the common cold.
- For over 35 years, patients and physicians have trusted Integrative
- Therapeutics for its dedication to quality, potency, and precision. Transparency in our sourcing and manufacturing processes is part of our promise of quality.
- We guarantee superior quality, from safety documentation to facility audits; we methodically test raw material batches to ensure purity and potency; and we test finished products to ensure they meet our labeling and shelf life expectations.
Reviews
There are no reviews yet.